Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Deffered Revenue: 2012-2022

Historic Non-Current Deffered Revenue for Veracyte (VCYT) over the last 6 years, with Mar 2022 value amounting to $278,000.

  • Veracyte's Non-Current Deffered Revenue fell 62.78% to $278,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $278,000, marking a year-over-year decrease of 62.78%. This contributed to the annual value of $343,000 for FY2021, which is 58.62% down from last year.
  • As of Q1 2022, Veracyte's Non-Current Deffered Revenue stood at $278,000, which was down 18.95% from $343,000 recorded in Q4 2021.
  • Veracyte's 5-year Non-Current Deffered Revenue high stood at $4.1 million for Q1 2018, and its period low was $278,000 during Q1 2022.
  • For the 3-year period, Veracyte's Non-Current Deffered Revenue averaged around $568,500, with its median value being $607,000 (2021).
  • Data for Veracyte's Non-Current Deffered Revenue shows a maximum YoY plummeted of 62.78% (in 2022) over the last 5 years.
  • Over the past 4 years, Veracyte's Non-Current Deffered Revenue (Quarterly) stood at $3.9 million in 2018, then reached $829,000 in 2020, then crashed by 58.62% to $343,000 in 2021, then crashed by 62.78% to $278,000 in 2022.
  • Its Non-Current Deffered Revenue was $278,000 in Q1 2022, compared to $343,000 in Q4 2021 and $552,000 in Q3 2021.